Cost and Allocation of Scarce CAR-T Therapy for Patients With Multiple Myeloma
Researchers sought to determine the allocation and cost involved with CAR-T therapy for patients with multiple myeloma.
Researchers sought to determine the allocation and cost involved with CAR-T therapy for patients with multiple myeloma.
Researchers sought to determine rates of infections for patients with multiple myeloma receiving autologous transplantation in India compared to other countries.
Researchers sought to determine whether carfilzomib- or pomalidomide-based therapeutic regimens would improve survival in MM following daratumumab.
Researchers sought to determine whether screening patients with MM after ASCT with FDG-PET would be able to identify patients with residual disease.
Researchers evaluated data from 270 patients with MM undergoing spine surgery to determine complication and reoperation rates.
Use of vitamin C and D supplementation evaluated for its efficacy for patients with AML undergoing intensive induction chemotherapy.
Aphexda is expected to be available in September 2023.
New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.
Researchers sought to assess and better characterize the risk of infection in patients with MM treated with bispecific antibodies.
Researchers sought to determine whether the CAR‑HEMATOTOX score would have prognostic value for both toxicity and treatment response in patients with R/R MM receiving CAR-T therapy.